Gables Capital Management’s Celgene Corp CELG Stock Holding History

Gables Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,625	Closed	-$459K	–	372
2019 Q3	$459K	Hold	4,625	–	–	0.32%	78
2019 Q2	$428K	Hold	4,625	–	–	0.35%	64
2019 Q1	$436K	Sell	4,625 -75	-2%	-$6.56K	0.35%	69
2018 Q4	$301K	Sell	4,700 -2,397	-34%	-$177K	0.26%	81
2018 Q3	$635K	Buy	7,097 +6,500	+1,089%	+$574K	0.48%	57
2018 Q2	$47K	Sell	597 -1,503	-72%	-$125K	0.04%	189
2018 Q1	$187K	Buy	+2,100	New	+$202K	0.17%	103

Other funds holding CELG

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Gables Capital Management's CELG Position: Q4 2019 in Review

Gables Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,625 shares — an estimated $459K sold.

Gables Capital Management first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $635K in Q3 2018. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Gables Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Gables Capital Management sold 4,625 Celgene Corp shares in Q4 2019, an estimated $459K.
Gables Capital Management first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
Gables Capital Management's Celgene Corp position peaked at $635K in Q3 2018.
3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Gables Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.